Aims: HFA-PEFF score has been proposed for diagnosing heart failure with preserved ejection fraction (HFpEF ... A Kaplan–Meier analysis was performed to calculate the cumulative incidence of all-cause ...

Heart failure remains a substantial burden for patients due to its high prevalence and limited therapeutic options. Heart ...

Patients with rheumatoid arthritis are associated with an increased risk for heart failure, particularly heart failure with preserved ejection fraction.

The following is a summary of “Reduced antioxidant high-density lipoprotein function in heart failure with preserved ejection ...

Background Early heart failure (HF) diagnosis is crucial to ensure that optimal guideline-directed medical therapy (GDMT) is ...

Heart failure remains a substantial burden for patients due to its high prevalence and limited therapeutic options. Heart failure is classified into two major clinical subtypes- heart failure with ...

Finerenone treatment vs placebo was associated with a reduced risk for new-onset diabetes by 24% among patients with HFmrEF or HFpEF.

Danielle Rasooly, PhD, of the Division of Aging at Brigham and Women’s Hospital, is the co-corresponding author of a paper published in Nature Cardiovascular Research, “Large-scale multi-omics ...

Understanding how patients with heart failure with preserved ejection fraction (HFPEF) die provides insight into the natural history and pathophysiology of this complex syndrome, thereby allowing ...

The key to treating congestive heart failure is addressing the underlying causes, and treatment is highly tailored to each ...

Objective: To provide an overview of heart failure with preserved ejection fraction (HFPEF), as well as its pathophysiology, diagnosis, and clinical evidence regarding its pharmacologic management.